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Introduction
Recently, it was proposed that alternative splicing may play a special role in evolution, by reducing negative selection pressure against large-scale mutations such as exon creation and loss [1] [2] [3] . Whereas most aspects of orthologous gene structures in human, mouse and rat are highly similar, alternatively spliced exons frequently are not conserved between these genomes 3, 4 . Such divergent features indicate an exon creation or loss event subsequent to the separation of these genomes during evolution. The fact that such exon creation / loss events are observed at a much higher rate for alternatively spliced exons than constitutive exons suggests that alternative splicing increases tolerance for such large-scale alterations of gene structure. Intuitively, this makes sense. Insertion or deletion of an exon is likely to disrupt a protein's reading frame, structure or function.
However, if a new exon is added as an alternatively spliced exon that is included in only 10% of transcripts of the gene, 90% of transcripts will still encode the original product, greatly reducing negative selection pressure against the new form.
To assess the validity of this hypothesis, it would be useful to find measures of negative selection pressure that are applicable to large-scale mutations such as exon creation. This requires somewhat different metrics of selection pressure than are typically applied to small-scale mutations (e.g. Ka/Ks for single nucleotide polymorphisms 5 ). One simple metric that can be applied to large-scale mutations is the frequency of occurrence of truncated protein reading frames that are likely targets of nonsense-mediated decay (NMD) 6 . If a transcript's open reading frame (ORF) has a premature termination codon (PTC; a STOP codon more than 50 nt upstream from its last exon-exon junction), it is likely to be degraded by NMD A second major question is the validity of the above hypothesis for diploid genes that are present in two copies in each cell (one from each of the two copies of its chromosome, in a diploid genome). Even if a new mutation completely eliminated production of the original transcript form from its gene, in a heterozygote the wildtype copy of the gene would ensure that the original transcript form would still be produced at 50% of its original level (instead of 0%, as would be the case if there was only one copy of the gene).
This might alleviate most of the negative effects of the mutation, so that alternative splicing of the mutation would not produce much additional relief of its negative selection pressure. This question was not addressed in our original model 3 , but is critical for evaluating this model.
Fortunately, this question can be tested by measuring negative selection pressure against PTC-containing isoforms on diploid chromosomes (e.g. autosomes) vs. on haploid chromosomes (e.g. sex chromosomes). The human X chromosome is haploid in males, and due to X inactivation, its gene expression is typically limited to a single chromosome in female cells as well 8 . In this paper we analyze the frequency of PTCs in the canonical splice form for each gene (which we will refer to as the "major" splice form) and in alternative splice forms for these genes (which we will refer to as "minor" splice forms), on both autosomal and X chromosomes in human and mouse.
Methods
We detected alternative splice forms for human and mouse by mapping mRNA and EST sequences onto genomic sequences as previously described isoforms from human and mouse was constructed from mRNA-EST-genomic multiple sequence alignments using our isoform generation algorithm described before 11 . Major isoforms were characterized as isoforms with maximum number of EST evidences for any given gene. Premature transcripts that are likely targets of Nonsense Mediated Decay were identified by checking for a STOP codon located over 50bp upstream of the last exon-exon junction sites.
Results
In our set of 13,384 transcript isoforms for 4,422 human genes, we found that 3.7% of major transcript isoforms (165 out of 4,422) had premature termination codons (PTCs), similar to the percentage reported for human mRNAs 11, 12 . However, 11.1% of the alternative-splicing (minor) isoforms had PTCs, a nearly 3-fold increase. We observed the same pattern in the mouse genome (3.6% for major isoforms vs. 9.3% for minor isoforms, see Table 1 ). These data indicate that alternative splicing is indeed associated with a substantial reduction in selection pressure against PTCs.
Analyzing the human data by chromosome, we found a large decrease in the frequency of PTCs on the X chromosome (3.5%) compared with autosomal chromosomes(8.9%) ( see Table1B) . X had the lowest PTC rate of all 23 chromosomes (Fig. 1) , and its difference vs. autosomal chromosomes was statistically significant (P<0.000006). Moreover, we found the same result on the mouse X chromosome (2.9%) vs. mouse autosomal chromosomes (7.2%). Thus diploidy also is associated with a significant reduction in selection pressure against PTCs, compared with haploid chromosomes (X). This pattern held true even when we limited our analysis to major splice forms: in human, 1.2% had PTCs on the X chromosome, vs. 3.8% on autosomal chromosomes. Does alternative splicing still provide relief from negative selection even on diploid chromosomes? For human autosomes, the frequency of PTCs was 3.8% for major splice forms, and 11.3% for minor splice forms (a three-fold increase). For mouse autosomal chromosomes, 3.7% of major forms vs. 9.7% of minor forms had PTCs. However, the strength of this effect appears to be strongest on the X chromosome. On the human X chromosome, the frequency of PTCs was 1.2% for major splice forms, vs. 4.6% for minor alternative splice forms, a nearly four-fold increase.
Discussion
These data provide independent evidence for the hypothesis that alternative splicing can relieve negative selection pressure. Whereas the original evidence for this hypothesis was based on comparative genomics analysis of exon creation / loss in mammalian genomes 3 , here we have focused on a different phenomenon-the incidence of premature termination codons that are likely to be targets for nonsense-mediated decay.
Sorek et al. have reported that Alu sequences sometimes occur in exons, but were always associated with alternative splicing (i.e. Alu were only found in alternatively-spliced exons) 13 . This also indicates reduced negative selection pressure in alternatively spliced exons.
Alternative splicing and diploidy appear to give about the same magnitude reduction (three-fold) in negative selection pressure against PTCs during recent mammalian evolution. In both cases, the effect of "having another functional copy" appears to increase tolerance for PTC isoforms by about three-fold. The effects of alternative splicing and diploidy appear to be independent and additive. Alternative splicing still relieves negative selection pressure even on diploid chromosomes, but this effect appears to be stronger on haploid chromosomes (e.g. nearly four-fold on the human X chromosome). The combined effect of alternative splicing and diploidy yields a more than nine-fold increase in tolerance for PTCs (from 1.2% in major splice forms on the X chromosome, to 11.3% in minor splice forms on autosomes).
These data may reflect genomic evidence for an important role for nonsense-mediated decay during mammalian evolution 14, 15 . The increased incidence of NMD-candidate forms observed on diploid chromosomes is consistent with NMD's function of degrading aberrant transcript forms that might produce dominant negative phenotypes. Since this function is useful for genes on diploid chromosomes (where the second copy of the chromosome can supply a working copy of the gene), but not on haploid chromosomes, this would be expected to give rise to more NMD-candidate forms on diploid chromosomes. 
